Summary.-In a case-control study, we investigated 169 women aged 15-49 years with malignant melanoma notified to the Oxford and South Western cancer registries during the years 1971-76, together with 507 matched controls. Data about medical, reproductive, drug and smoking histories were obtained both by reviewing general practitioner (GP) records and from the women themselves by postal questionnaires. There was no significant evidence of any overall increase in the risk of melanoma in oral contraceptive (OC) users (data from GP records-ever use vs never use, relative risk (RR) 1.34, 9500 confidence limits 0.92-1 96; corresponding data from postal questionnaires-RR 1-13, limits 0.73-1-75). However, although not significant, the risk estimated from data in the postal questionnaires was higher in women who had used OCs for 5 years or more (use ;5 yrs vs never use, RR 1.57, limits 0-83-3.03).
ALTHOUGH MALIGNANT MELANOMA remains a relatively rare tuimour, the incidence of and mortality from the disease have increased more in recent years than those of most other cancers. These increases have been noted in both sexes and across all age groups, though they appear most pronounced in the middleaged (Elwood & Lee, 1975; Lee, 1976; Magnus, 1977; Teppo et al., 1978; Malec & Eklung, 1978; Lee & Strickland, 1980) . In 1977, Beral et al. reported an association between oral contraceptive (OC) use and malignant melanoma in 3 separate sets of data collected in California. However, the association reached statistical significance in only one set; amongst almost 18,000 women aged 17-59 years registered with a health-maintenance organization, a history of skin cancer was more common in those who had used OCs, particularly those with a duration of use of 4 years or more. Unfortunately, the analyses were based on small numbers of women with malignant melanoma, and no data were available on possible confounding variables, such as exposure to sunlight.
An association between OCs and malignant melanoma would be biologically plausible. First, large doses of oestrogen, or smaller doses given with simultaneous progestogen, have been shown to increase both the melanocyte count and the intracellular and extracellular melanin content in guinea pigs (Sneu & Bischitz, 1960) . Secondly, oestrogen receptors have been found in human malignant melanoma cells (Fisher et al., 1976) . Finally, one of the more commonly reported side effects of OC use is hyperpgimentation, especially of the face, which increases in incidence with duration of OC use (Jelinek, 1970; Carruthers, 1966) .
California is a high-risk area for melanoma, whereas the incidence rates in the United Kingdom are consistently low (Waterhouse et al., 1976 (during 1971-3) . With the permission of the appropriate consultant, the hospital notes relating to each case were reviewed to verify the histological diagnosis and to obtain the name of each patient's general practitioner (GP). The GP was then contacted and arrangements made for a research wAorker to visit the practice. During the visit, the GP records (obtained from the Family Practitioner Committee if the patient had died) wvere reviewed to obtain data on the activity of the disease, past medical history, reproductive history, use of drugs, smoking history and occupation. At the same time, 3 female controls matched by age group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49 years) (53) 61 (12) 18 (4) 158 (31) 7 (1) questionnaire. In addition, there were no important, differences between these cases and controls with respect to social class, number of children, past medical history (including a history of difficulty in conceiving) or smoking history.
Our main puirpose in carrying out this study was to re-examine the relationship between OCs and malignant melanoma. (60) 3 (3) 5 (5) 2 (2) 12 (11) 17 (15) 5 (5) 214 (63) 10 (3) 12 (4) 13 (4) (3) 14 (9) 6 (4) 23 (15) 17 169 Controls 344 (69) 26 (5) 10 (2) 20 (4) 36 (7) 15 (3) 51 (10) 5 507 A separate analysis of the data on OC use obtained from the GP records, which, unlike the questionnaire data, included the women who subsequently died, also failed to reveal any significant differences (Table  IV) There were no significant differences between the cases and controls in their use of the other drugs which we specifically considered phenothiazines, methyldopa and reserpine. It is, however, interesting that the GrP records indicated that onefifth of each group had been prescribed phenothiazines, usuallv for relatively minor psychological problems, often described as "depression". Again, the postal questionnaire data gave a much lower figure 1% of both cases and controls mentioned a phenothiazine.
Data were also collected on those variables which have previously been shown to be associated with melanoma. The cases were more likely to describe themselves as fair-skinned (1200 cases, 900 controls) and to have blonde or red hair (28% cases, 16% controls). Seventeen per cent of cases and 210 of controls gave a history suggestive of chloasma. When asked about the reaction of their skin to sun the cases were significantly more likely to reply that they burned easily (78% cases, 670o controls, P< 0.05). There were no differences between cases and controls in the amount of work or leisure time which they spent out of doors. However, the cases were slightly more likely to have spent some of this time deliberately tanning their legs (7700 cases, 69% controls) and trunk (64% cases, 5300 controls) and were also more likely to have tanned themselves while on holiday abroad (legs-78% cases, 7:3% controls; trunk 7000 cases, 6700 controls), though these differences were not statistically significant. There was no suggestion that women with a particular skin colouring were more or less likely to lie in the sun. The prevalence of sunlamp use was low, but it was significantly higher in cases than in controls (8% cases, 30o controls, P < 005).
Most Finally, the data from the Oxford/ Family Planning Association contraceptive study showed that there were 12 incident cases of malignant melanoma. Unexpectedly, the disease was found to be quite strongly negatively associated with OC use. Thus the age-standardized incidence rates per 1000 woman-years of observation were 0 17 in those never using OCs (8 cases), 0-06 in those using OCs for up to 4 years (3 cases) and 0-02 in those using OCs for more than 4 years (1 case).
DISCUSSION
An important limitation of our casecontrol study is that the full range of information was available only for the surviving women who responded to our questionnaire. Fortunately, when the data on OC use obtained from GP records and from the postal questionnaire were checked for each woman, there was reasonable agreement. It is therefore unlikely that conflicting findings on OC use would have emerged had it been possible to collect information about those who had died or who were uncooperative by means of postal questionnaires. Furthermore, other previously described risk factors for melanoma such as fair skin (Gellin et al., 1969;  Lee, 1975; Crombie, 1979) , blonde or red hair (Gellin et al., 1969; Nordlund & Lerner, 1977) , and Celtic origin (Lee, 1975; Lane-Brown et al., 1971) 
